Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark the largest end-to-end CDMO in Europe

Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark the largest end-to-end CDMO in Europe

Submitted by admin on June 30, 2022 - 10:12pm
Source: 
Biopharma Reporter
News Tags: 
Fujifilm
drug manufacturing
CDMOs
Headline: 
Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark the largest end-to-end CDMO in Europe
snippet: 

Fujifilm Corporation is to invest US$1.6bn (€1.4bn) to boost the business of its subsidiary, Fujifilm Diosynth Biotechnologies (FDB), a contract development and manufacturing organization (CDMO).

Do Not Allow Advertisers to Use My Personal information